BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 12081741)

  • 1. Angiosarcoma in the breast: a population-based cohort from Sweden.
    Olander S; Wennstig AK; Garmo H; Holmberg L; Nilsson G; Blomqvist C; Karlsson F; Wickberg Å; Wärnberg F; Sund M; Wadsten C
    Br J Surg; 2023 Nov; 110(12):1850-1856. PubMed ID: 37708086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes.
    Belkacemi Y; Hanna NE; Besnard C; Majdoul S; Gligorov J
    Front Oncol; 2018; 8():112. PubMed ID: 29719816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary and supraclavicular recurrences are rare after axillary lymph node dissection in breast cancer.
    Siponen ET; Vaalavirta LA; Joensuu H; Leidenius MH
    World J Surg; 2012 Feb; 36(2):295-302. PubMed ID: 22202994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification.
    Galalae RM; Schultze J; Eilf K; Kimmig B
    Radiat Oncol; 2010 Nov; 5():103. PubMed ID: 21050439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sentinel node in breast cancer.
    Collins CD
    Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S10-8. PubMed ID: 18852076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.
    Langer I; Guller U; Berclaz G; Koechli OR; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M
    Ann Surg; 2007 Mar; 245(3):452-61. PubMed ID: 17435553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of axillary skip metastases in the era of sentinel lymph node biopsy in breast cancer.
    Keskek M; Balas S; Gokoz A; Sayek I
    Surg Today; 2006; 36(12):1047-52. PubMed ID: 17123131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sentinel node in breast cancer: an update.
    Collins CD
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S3-9. PubMed ID: 16361134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy and selective lymph node clearance--impact on regional control and survival in breast cancer and melanoma.
    Nieweg OE; van Rijk MC; Valdés Olmos RA; Hoefnagel CA
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):631-4. PubMed ID: 15875179
    [No Abstract]   [Full Text] [Related]  

  • 10. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
    Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
    Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate treatment of symptomatic breast cancer.
    Kingsmore DB; Hole DJ; Gillis CR; George WD
    Br J Surg; 2005 Apr; 92(4):422-8. PubMed ID: 15609383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast-conserving treatment of early breast cancer: survival and recurrence in community hospitals in southeastern Netherlands.
    Voogd AC; Coebergh JW; Crommelin MA; van der Heyden LH; Kluck HM
    Neth J Surg; 1991 Aug; 43(4):105-9. PubMed ID: 1944987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ipsilateral breast tumor recurrence following conservative surgery and radiation therapy.
    DiPaola RS; Orel SG; Fowble BL
    Oncology (Williston Park); 1994 Dec; 8(12):59-68; discussion 71, 75-6. PubMed ID: 7888313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of axillary recurrence after conservative breast surgery.
    Fredriksson I; Liljegren G; Arnesson LG; Emdin SO; Palm-Sjövall M; Fornander T; Holmqvist M; Holmberg L; Frisell J
    Br J Surg; 2002 Jul; 89(7):902-8. PubMed ID: 12081741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; de Boer R; van der Sangen MJ; Roumen RM; Rutten HJ; Coebergh JW
    Eur J Surg Oncol; 2001 Apr; 27(3):250-5. PubMed ID: 11373100
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.